** Shares of animal diagnostics maker IDEXX Laboratories IDXX.O rise 1.13% to $678.02 premarket
** Co reports Q4 adj. profit of $3.08/shr vs analysts' average estimate of $2.93/shr - LSEG data
** Brokerage Leerink Partners said non‑wellness vet visits, which drive most recurring diagnostics revenue, held up better than overall visit volumes in Q4
** Co's quarterly revenue of $1.091 billion beats analysts' average expectation of $1.073 billion
** Shares were up ~64% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))